Skip to main content

Jessica Hagen

By Jessica Hagen | 11:32 am | March 21, 2023
The company will use the funds to circulate its ArteraAI Prostate Test and to develop tests to support individualized therapy options for other cancers.
By Jessica Hagen | 03:25 pm | March 20, 2023
The collaboration will expand MedArrive's maternal care services for managed Medicaid health plan members.
By Jessica Hagen | 11:05 am | March 20, 2023
Ida Tin, cofounder and chairwoman at Clue, explains how she sees the fall of Silicon Valley Bank affecting femtech investments and how the sector could progress fruitfully.
By Jessica Hagen | 11:24 am | March 17, 2023
The company also announced a new payer network and revenue cycle management service.
By Jessica Hagen | 01:59 pm | March 16, 2023
The funds will be used to accelerate the adoption of the platform's applied behavior analysis-focused tools.
By Jessica Hagen | 12:11 pm | March 16, 2023
The acquisition expands the senior-focused company's offerings to include a workflow management program and value-based care reimbursement assistance.
By Jessica Hagen | 02:32 pm | March 15, 2023
Fire1, a remote patient monitoring company for heart failure patients, and Protai, an AI-powered drug discovery platform, scored funding.
By Jessica Hagen | 12:26 pm | March 15, 2023
The platform connects adults with conditions like autism, ADHD, OCD or Tourette's with care teams trained to help with their specific needs.
By Jessica Hagen | 02:28 pm | March 14, 2023
BlueRock Therapeutics will utilize Rune Labs' StriveStudy clinical trial platform and FDA-cleared Apple Watch data-collection tool to monitor Parkinson's disease.
By Jessica Hagen | 01:31 pm | March 13, 2023
The startup's technology allows telehealth companies and virtual medical clinics to verify a patient's health insurance coverage manually or programmatically.